Ingevity (NGVT) is a Top-Ranked Growth Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.
Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.
Why This 1 Growth Stock Should Be On Your Watchlist
Growth investors build their portfolios around companies that are financially strong and have a bright future, and the Growth Style Score helps take projected and historical earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Ingevity (NGVT)
Based in North Charleston, SC, Ingevity Corporation is a global producer of high performance activated carbon materials and specialty chemicals. The company provides innovative solutions through proprietary formulated products. Ingevity started trading in May 2016 after its spinoff from the WestRock Company.
NGVT is a Zacks Rank #3 (Hold) stock, with a Growth Style Score of A and VGM Score of A. Earnings are expected to grow 13.8% year-over-year for the current fiscal year, with sales growth of 14.2%.
Three analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.23 to $5.95 per share for 2022. NGVT boasts an average earnings surprise of 22.6%.
Looking at cash flow, Ingevity is expected to report cash flow growth of 5.5% this year; NGVT has generated cash flow growth of 20.3% over the past three to five years.
NGVT should be on investors' short lists because of its impressive growth fundamentals, a good Zacks Rank, and strong Growth and VGM Style Scores.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ingevity Corporation (NGVT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
